Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | BHVN | CRSP | ||
| Company | Ultragenyx Pharmaceu | Biohaven Ltd | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 46.07 | 44.98 | 46.37 | ||
| High | 47.47 | 47.15 | 48.00 | ||
| Low | 45.47 | 44.98 | 45.85 | ||
| Last | 47.24 | 45.59 | 47.88 | ||
| Change | +1.22 | +0.40 | +1.59 | ||
| % Change | +2.65% | +0.89% | +3.43% | ||
| Volume | 593,800 | 691,000 | 1,504,200 | ||
| 20-Day Average Volume | 986,680 | 756,895 | 1,922,935 | ||
| Previous Close | 46.02 | 45.19 | 46.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 49.12 | 49.49 | 49.20 | ||
| 20-Day Raw Stochastic | 34.96% | 20.42% | 17.48% | ||
| 20-Day Relative Strength | 40.30% | 43.69% | 48.63% | ||
| Weighted Alpha | +12.71 | +38.56 | -31.22 | ||
| Today's Opinion | 24% Sell | 40% Buy | 80% Sell | ||
| Previous Opinion | 24% Sell | 40% Buy | 80% Sell | ||
| Last Month's Opinion | 48% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.56% since 11/15/24 | +2.70% since 11/15/24 | +1.33% since 11/15/24 | ||
| Low | 43.04 on 11/18/24 | 43.18 on 11/18/24 | 45.51 on 11/21/24 | ||
| High | 47.47 on 11/22/24 | 47.66 on 11/21/24 | 48.28 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -13.78% since 10/22/24 | -13.41% since 10/22/24 | -0.33% since 10/22/24 | ||
| Low | 43.04 on 11/18/24 | 43.18 on 11/18/24 | 45.44 on 10/23/24 | ||
| High | 56.38 on 10/23/24 | 54.98 on 11/06/24 | 59.07 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | -16.18% since 08/22/24 | +14.09% since 08/22/24 | +0.80% since 08/22/24 | ||
| Low | 43.04 on 11/18/24 | 35.29 on 09/12/24 | 43.42 on 09/06/24 | ||
| High | 60.37 on 09/16/24 | 55.70 on 10/08/24 | 59.07 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +15.00% since 05/22/24 | +20.01% since 05/22/24 | -15.70% since 05/22/24 | ||
| Low | 37.02 on 06/18/24 | 26.80 on 05/29/24 | 43.42 on 09/06/24 | ||
| High | 60.37 on 09/16/24 | 55.70 on 10/08/24 | 67.88 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,362,331 | 4,610,152 | 4,086,701 | ||
| Shares Outstanding, K | 92,344 | 101,122 | 85,353 | ||
| Annual Sales | 434,250,000 | 0 | 371,210,000 | ||
| Annual Net Income | -606,640,000 | -408,170,000 | -153,610,000 | ||
| Last Quarter Sales | 139,490,000 | 0 | 600,000 | ||
| Last Quarter Net Income | -133,520,000 | -160,300,000 | -85,940,000 | ||
| 60-Month Beta | 0.58 | 1.31 | 1.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 11/05/24 | -1.70 on 11/12/24 | -1.01 on 11/05/24 | ||
| Latest Earnings Date | 11/05/24 | 11/12/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||